Evaluation of Gait Symmetry in Upper Extremity Burn Injuries

Status Completed

Clinical Trial Summary

Thirty patients with unilateral burn injury, and 60 healthy subjects will be included in this study. Participants with burn injury will evaluate with the following assessment tools: Demographic data; age, gender, height, body mass index; burn characteristics; type of burn injury, degree of burn injury, localization of burn injury and total burn surface area will be recorded. Gait parameters (step length, stride length, base support, step time, cycle time, cadence, velocity, single support, double support, swing ( % of gait cycle) and stance (% of gait cycle). will be recorded via computerized system. And gait symmetry will be calculated via formule. Participants' kinesiophobia level will be evaluated with Tampa kinesiophobia scale. Their pain will be assessed by visual analog scale. Their arm swing will be evaluated by a scale.

Clinical Trial Description

Thirty individuals with lower extremity burn injury and sixty healthy subjects will be included in this study. Participants with burn injury will be included if they are aged of 18-50, able to walk independently at least 10 meters. Healthy subjects will be included if there are no orthopedic, neurological or musculoskeletal disorders that affect gait.

1. Group: 30 Patients with burn injury

2. Group: 30 healthy subjects (When evaluating the gait analysis, their arm will not be restricted (Their natural walking)

3. Group : 30 healthy subject (When evaluating the gait analysis, their arm will be restricted )

Participants will evaluate with the following assessment tools: Demographic data; age, gender, height, body mass index; burn characteristics; type of burn injury, degree of burn injury, localization of burn injury and total burn surface area will be recorded.

All subjects' gait analysis will be conducted via GAITRite (computerized) system.

GAITRite system for gait parameters (step length, stride length, base support, step time, cycle time, cadence, velocity, single support, double support, swing ( % of gait cycle) and stance (% of gait cycle), Tampa Kinesiophobia scale for kinesiophobia level, visual analog scale for pain, a scale that developed by us for arm swing will be used.

These evaluations will be applied one time for participants. These evaluations will be made within 5 days following burn injury. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03759613
Study type	Interventional
Source	Hacettepe University
Contact
Status	Completed
Phase	N/A
Start date	December 1, 2018
Completion date	June 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02210208` - A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.	N/A
Withdrawn	`NCT02241941` - Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury	Phase 4
Completed	`NCT05063409` - Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting	N/A
Completed	`NCT03730688` - Non-invasive Limb Compartment Pressure Measurement	N/A
Recruiting	`NCT04368117` - STAT: Standard Therapy Plus Active Therapy	N/A
Terminated	`NCT01773083` - Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma	Phase 3
Completed	`NCT02092701` - Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period	N/A
Recruiting	`NCT06263296` - Smartphone Assisted Self-management Education for Adult Burn Patient at Aftercare	N/A
Completed	`NCT02145130` - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects	Phase 1
Completed	`NCT01618630` - Amino Acid Supplementation in Recovery From Severe Burns	N/A
Recruiting	`NCT05876442` - Efficacy of EPSW Plus HILT on Carpal Tunnel Syndrome Post Burn Injury	N/A
Completed	`NCT04417439` - The Effect of Acute Phase Treatment Approaches on Creatine Kinase and the Musculoskeletal System in Different Types of Burns
Completed	`NCT02417779` - Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy	N/A
Completed	`NCT02417805` - Cutaneous Microcirculation After Remote Ischemic Preconditioning	N/A
Completed	`NCT02417818` - Cutaneous Microcirculation After Plasma Therapy	N/A
Completed	`NCT01404026` - Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury	N/A
Completed	`NCT03204669` - Trace Element Repletion Following Severe Burn Injury	N/A
Recruiting	`NCT04947449` - Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
Not yet recruiting	`NCT05532488` - Inulin in Burn-induced Insulin Resistance	N/A
Recruiting	`NCT02189538` - Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.